Annual Drug Patent Expirations for LIVALO
Livalo is a drug marketed by Kowa Co and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for LIVALO.
The generic ingredient in LIVALO is pitavastatin calcium. One supplier is listed for this compound. Additional details are available on the pitavastatin calcium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com